Pregnancy

BillionToOne’s UNITY Fetal Antigen NIPT Transforms Care in Maternity Health Deserts

The UNITY Prenatal Test Expands Access to Maternal Care in Remote Communities, Reducing Travel Burdens for High-Risk Pregnancies MENLO PARK,…

24 hours ago

Prytime Medical Announces Key Prolonged REBOA Advancements to Treat Maternal Hemorrhage

BOERNE, Texas, Dec. 20, 2024 /PRNewswire/ -- Prytime Medical, The REBOA Company™, is proud to announce significant strides made in…

1 day ago

YORVIPATH® (Palopegteriparatide) Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in Adults

COPENHAGEN, Denmark, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as…

2 days ago

March of Dimes Awards Dr. Dennis Lo the 2025 March of Dimes Richard B. Johnston, Jr., MD Prize

Recognized for discovery of cell-free fetal DNA in maternal blood and creation of noninvasive prenatal testing (NIPT), used by as…

4 days ago

Aeroflow Breastpumps Awarded Contract to Provide Breast Pumps to Medicaid Members in Montana

Aeroflow Breastpumps won the state RFP in Montana to provide mothers under Medicaid with electric breast pumps and other maternal…

4 days ago

Prevounce Health Releases Pregnancy-Validated Blood Pressure Monitor for Remote Patient Monitoring

Pylo 900-LTE blood pressure monitor is now clinically validated and FDA cleared for use during pregnancy, addressing the ongoing crisis…

1 week ago

Pomelo Care Publishes Peer-Reviewed Data Demonstrating Significant Impact Of Its Virtual Maternal Health Care Model

Data Shows Pomelo's Virtual Care Model Reduces Total Cost of Maternal Care in Medicaid Population, Lowers NICU and ER Utilization for…

1 week ago

60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital

The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is…

1 week ago

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

Presentations complement topline data with new data from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive…

1 week ago

NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App

JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast…

2 weeks ago